$9.76 -0.41 (-4.03%)
11/30/2009 10:30 AM

Enzon Pharmaceuticals, Inc. (ENZN)

CAPS Rating: 2 out of 5

A biopharmaceutical company dedicated to the development and commercialization of therapeutics to treat patients with cancer and adjacent diseases.

Featured Broker Partners